Skip to main content

Table 2 Characteristics of 45 P. aeruginosa strains from the burn unit with non-MDR phenotypes1

From: Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in burns care

Strain

Date of isolation

Patient and/or Origin

P

E

SSD

SSDC

BetG

BetL

Sulf

Chlor

PAB01

01-2005

13

Burn wound

G

7

24.7

24.3

24.3

19.3

46.5

17.9

PAB02

01-2005

13

Burn wound

G

7

25.0

24.4

21.6

18.6

47.0

16.4

PAB04

02-2005

24

Burn wound

H

39

23.0

22.0

20.4

17.4

51.0

14.6

PAB05

03-2005

16

Burn wound

E

2

26.0

23.8

18.7

18.2

48.0

16.1

PAB06

03-2005

16

Burn wound

E

2

25.6

25.2

21.1

17.4

44.6

19.6

PAB09

03-2005

26

Urine

F

36

25.6

25.6

22.7

18.2

47.0

18.0

PAB10

03-2005

26

Respiratory

F

36

24.0

23.6

21.6

17.2

42.0

17.2

PAB11

03-2005

26

Respiratory

F

36

24.0

24.6

20.8

17.0

44.0

15.0

PAB12

04-2005

16

Blood

E

2

25.0

21.6

21.2

17.6

45.0

20.4

PAB16

04-2005

16

Urine

E

2

26.8

25.8

23.7

17.5

44.5

21.2

PAB17

04-2005

16

Urine

E

2

27.6

26.0

22.6

18.0

48.0

22.0

PAB19

06-2005

20

Burn wound

I

14

22.6

22.8

18.9

19.9

45.0

24.1

PAB24

09-2005

23

Burn wound

J

37

25.0

23.6

21.2

18.6

46.0

20.6

PAB27

08-2005

15

Burn wound

ND

6

16.0

14.6

21.6

19.6

47.0

20.4

PAB28

08-2005

15

Burn wound

ND

6

26.1

27.3

21.7

17.1

43.6

18.9

PAB38

01-2007

19

Urine

ND

11

16.0

15.4

19.2

18.2

47.0

20.6

PAB40

01-2007

19

Burn wound

ND

35

20.9

21.8

19.4

17.4

48.5

19.2

PAB41

01-2007

19

Burn wound

ND

11

15.2

15.4

17.2

18.0

46.0

20.4

PAB49

04-2007

18

Burn wound

ND

10

21.8

20.3

20.3

18.6

45.3

19.6

PAB52

04-2007

21

Respiratory

ND

15

24.7

23.6

18.9

17.5

45.6

15.0

PAB53

05-2007

25

Urine

ND

16

25.6

26.0

18.7

17.0

37.0

18.5

PAB54

05-2007

14

Burn wound

ND

38

27.3

29.0

22.6

20.3

45.6

17.8

PAB55

05-2007

18

Burn wound

ND

10

16.0

14.8

20.2

17.0

43.0

20.2

PAB61

06-2007

22

Burn wound

ND

17

24.0

23.6

19.2

18.8

48.0

21.0

PAB63

07-2007

14

Urine

ND

18

22.4

22.6

19.8

18.0

46.0

18.6

PAB66

08-2007

17

Burn wound

ND

9

25.8

23.8

20.0

16.2

44.0

17.6

PAB67

08-2007

17

Blood

ND

9

25.0

24.2

20.0

18.6

45.0

17.6

PABH09

NA

Trap

K

3

20.0

18.6

17.2

16.6

40.0

15.2

PABH10

NA

Trap

ND

19

19.6

20.0

17.0

17.4

44.0

24.2

PABH12

NA

Basin washing-machine

ND

4

23.4

22.6

21.0

18.2

42.0

17.0

PABH13

NA

Basin washing-machine

ND

4

23.0

23.2

22.4

18.2

41.0

13.0

PABH14

NA

Water

K

3

24.4

26.2

21.6

17.0

42.0

16.0

PABH19

10-2006

NA

ND

21

25.1

23.9

21.1

17.6

42.0

18.6

PABH20

10-2006

Basin washing-machine

ND

22

26.2

25.4

23.3

20.4

44.0

18.8

PABH21

10-2006

Water

ND

4'

28.9

27.6

21.2

16.8

46.0

18.8

PABH22

10-2006

Shower

ND

34

27.6

30.5

22.9

18.9

45.5

15.8

PABH24

01-2007

Trap

ND

3'

22.4

21.2

22.2

19.8

42.0

17.6

PABH25

01-2007

Mattress

D

34

26.2

26.2

18.0

17.1

45.0

16.7

PABH26

01-2007

Table

ND

34

26.6

25.8

22.6

16.0

45.0

19.2

PABH27

01-2007

NA

ND

34

26.4

27.2

23.8

15.8

44.0

17.8

PABH28

01-2007

Trap

ND

3

27.0

27.8

23.4

19.0

43.0

17.8

PABH30

01-2007

Basin washing-machine

ND

23

26.2

25.0

24.4

19.6

43.0

19.0

PABH31

05-2007

Infusion support

ND

24

26.8

25.6

19.8

19.6

43.0

16.0

PABH33

05-2007

Faucet filter

ND

25

21.2

18.6

17.6

18.6

43.0

20.6

PABH34

01-2007

NA

ND

26

23.0

22.8

23.2

18.0

44.0

17.8

  1. See Table 1 for legend. NA: data not available.
  2. 1Antibiotics susceptibility phenotypes were highly diverse among the non-MDR isolates